References
- PeeryAFDellonESLundJBurden of gastrointestinal disease in the United States: 2012 updateGastroenterology2012143511791187e1322885331
- ForsmarkCEBaillieJAGA Institute Clinical Practice and Economics Committee; AGA Institute Governing BoardAGA Institute technical review on acute pancreatitisGastroenterology200713252022204417484894
- SpanierBWTuynmanHAvan der HulstRWDijkgraafMGBrunoMJAcute Pancreatitis and Concomitant Use of Pancreatitis-Associated DrugsAm J Gastroenterol2011106122183218821912439
- BalaniARGrendellJHDrug-induced pancreatitis: incidence, management and preventionDrug Saf2008311082383718759507
- CohenDReports of pancreatitis are 20–30 times more likely with GLP-1 drugs, analysis findsBMJ2013346f260723613543
- American Diabetes AssociationStandards of medical care in diabetes – 2014Diabetes Care201437Suppl 1S14S8024357209
- US Food and Drug AdministrationFDA approves Invokana to treat type 2 diabetes [press release]US Food and Drug Administration2013 Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm345848.htmAccessed February 22, 2015
- ChaoECHenryRRSGLT2 inhibition-a novel strategy for diabetes treatmentNat Rev Drug Discov20109755155920508640
- ShaSDevineniDGhoshACanagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjectsDiabetes Obes Metab201113766967221457428
- StenlofKCefaluWTKimKAEfficacy and safety of Canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exerciseDiabetes Obes Metab201315437238223279307
- ValentineVHinnenDClinical implications of canagliflozin treatment in patients with type 2 diabetesClin Diabetes201533151325653467
- Invokana® (canagliflozin) [prescribing information]Titusville, NJJanssen Pharmaceuticals, Inc2014
- HungWYAbreu LanfrancoOContemporary review of drug-induced pancreatitis: A different perspectiveWorld J Gastrointest Pathophyiol201454405415
- BadalovNBaradarianRIswaraKLiJSteinbergWTennerSDrug-induced acute pancreatitis: an evidence-based reviewClin Gastroenterol Hepatol20075664865117395548
- VermaRCanagliflozin-Associated Acute PancreatitisAm J Ther Epub 2014 Sep 2
- FimognariFLCorsonelloAPastorellRAntonelli-IncalziRMetformin-induced pancreatitisDiabetes Care2006295118316644670
- AlsubaieSAlmalkiMHMetformin induced acute pancreatitisDermatoendocrinol20135231731824194972
- NairSYadavDPitchumoniCSAssociation of diabetic ketoacidosis and acute pancreatitis: observations in 100 consecutive episodes of DKAAm J Gastroenterol200095102795280011051350
- NaranjoCABustoUSellersEMA method for estimating the probability of adverse drug reactionsClin Pharmacol Ther19813022392457249508